Antibody Responses After SARS-CoV-2 mRNA Vaccination in Adults With Inflammatory Bowel Disease

Ann Intern Med. 2021 Dec;174(12):1768-1770. doi: 10.7326/M21-2483. Epub 2021 Oct 12.
No abstract available

Publication types

  • Letter

MeSH terms

  • 2019-nCoV Vaccine mRNA-1273 / immunology*
  • Adult
  • Antibodies, Viral / blood*
  • BNT162 Vaccine / immunology*
  • COVID-19 / prevention & control*
  • Female
  • Humans
  • Immunocompromised Host*
  • Immunoglobulin G / blood
  • Immunosuppressive Agents / therapeutic use
  • Inflammatory Bowel Diseases / drug therapy
  • Inflammatory Bowel Diseases / immunology*
  • Male
  • Middle Aged
  • SARS-CoV-2

Substances

  • Antibodies, Viral
  • Immunoglobulin G
  • Immunosuppressive Agents
  • 2019-nCoV Vaccine mRNA-1273
  • BNT162 Vaccine